Satsuma Pharmaceuticals Inc (STSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2001 | 12-2000 | 09-2000 | 06-2000 | 03-2000 | |
| Assets | |||||
| Cash & Cash Equivalents | 78,224 | 62,510 | N/A | N/A | N/A |
| Securities And Investments | 458,117 | 486,182 | 0 | 0 | 0 |
| Loans Gross | 1,999,555 | 1,982,309 | N/A | N/A | N/A |
| Allowance For Loan Losses | 0 | -16,740 | 0 | 0 | 0 |
| PPE Net | 49,854 | 50,220 | N/A | N/A | N/A |
| Intangibles | 49,078 | 50,347 | 0 | 0 | 0 |
| Other assets | 17,299 | 37,881 | 0 | 0 | 0 |
| Total Assets | $2,652,127 | $2,652,709 | $N/A | $N/A | $N/A |
| Liabilities | |||||
| Total deposits | 1,692,503 | 1,724,219 | N/A | N/A | N/A |
| Federal Funds Purchased | 141,847 | 110,326 | N/A | N/A | N/A |
| Short Term Debt | 110,000 | N/A | N/A | N/A | N/A |
| Long Term Debt | N/A | 110,000 | N/A | N/A | N/A |
| Other liabilities | 560,446 | 566,826 | 0 | 0 | 0 |
| Total Liabilities | $2,504,796 | $2,511,371 | $N/A | $N/A | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 8,922 | 8,911 | N/A | N/A | N/A |
| Additional Paid Capital | 78,071 | 78,035 | N/A | N/A | N/A |
| Retained earnings | 61,535 | 57,950 | N/A | N/A | N/A |
| Other shareholders' equity | -1,197 | -3,558 | 0 | 0 | 0 |
| TOTAL | $147,331 | $141,338 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $2,652,127 | $2,652,709 | $0 | $0 | $0 |